DUROLANE is a hyaluronic acid treatment
for osteoarthritis of the knee and hip,
based upon NASHA technology
(Non-Animal StabilizedHyaluronic Acid).
DUROLANE provides significant relief
DUROLANE provides a non-surgical alternative
DUROLANE is the only non-animal HA treatment currently available that can
provide up to 6 months pain relief with a single injectio
n.1

The principle advantage of DUROLANE is NASHA, which dramatically increases
the intra-articular residence time
2, therefore reducing the number of
injections per course of treatment.

DUROLANE is an incredibly safe treatment; NASHA™ gels have been used for
over 20 years in the health and beauty industry with few reactions. NASHA™
gels are contained in the only hyaluronic acid derived products that have
been safely used in paediatric medicine.
3

In clinical studies, joint fluid therapy has proven to provide significant relief
from OA knee pain. Groups receiving DUROLANE Joint Fluid Therapy were
shown to have no greater incidence or severity of side effects than the
control group receiving placebos.

In addition, joint fluid therapy represents an opportunity for physicians to
provide a total treatment plan to OA sufferers. By offering an effective pain
relief treatment in the early stages of OA, physicians have the ability to
better serve patients and to develop an extensive long-term case history.

To view a more comprehensive analysis, click here or download additional
information fromthe Clinical Data tab on the right

Site Design - Pollution Design 2008